AMIGO1 Antibodies

Santa Cruz Biotechnology offers a broad range of AMIGO1 monoclonal antibodies for research focused on understanding AMIGO1's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AMIGO1, or Adhesion Molecule with Ig-like Domain 1, facilitates cell adhesion and participates in critical signaling pathways. Research has shown AMIGO1's significant involvement in neuronal development, with implications in several neurological disorders. AMIGO1 expression patterns have been observed across different tissue types, highlighting its broad biological relevance. Ongoing studies continue to reveal new functions of AMIGO1 in cellular communication and tissue development. Current research suggests AMIGO1 may serve as a potential therapeutic target for various neurological conditions. Understanding AMIGO1's molecular mechanisms could lead to breakthrough treatments in neuroscience. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of AMIGO1's role in health and disease.